AN IMPROVED PROCESS FOR THE PREPARATION OF LURASIDONE AND ITS INTERMEDIATE
The present invention provides an improved process for preparation of the substantially pure (3a R,7a R)-4'-(benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,1'-piperazin]-1'-ium methanesulfonate (referred to as compound-II), which is useful as a key intermediate for the synthesis o...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | ZALTE, YOGESH TIWARI, SHASHI KANT WARPE, MANIKRAO WAGH, GANESH KRISHNMURTHY, DHILEEPKUMAR GHARPURE, MILIND REVANAPPA, GALGE |
description | The present invention provides an improved process for preparation of the substantially pure (3a R,7a R)-4'-(benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,1'-piperazin]-1'-ium methanesulfonate (referred to as compound-II), which is useful as a key intermediate for the synthesis of lurasidone ((3a R,4S,7R,7a S)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3- yl)piperazin-1ylmethyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione). The process comprises reaction of the compound-III (as described herein) with the compound-IV (as described herein) in the presence of a solvent mixture selected from an alcohol and water; and a base The improved process for the preparation of compound II provides the product with total amount of unreacted compound-IV as impurity in less than 0.06 % and the product with HPLC purity as ≥ 99.8%. The process further refers purification of Lurasidone hydrochloride, wherein the product contains the residual acetone < 5000 ppm.
La présente invention concerne un procédé amélioré de préparation du (3a R,7a R) -4 '- (benzo [d] isothiazol -3-yl) octahydrospiro [isoindole -2,1 '-pipérazin]-1 '-ium méthanesulfonate sensiblement pur (désigné composé -II), qui est utile comme intermédiaire clé pour la synthèse du lurasidone ((3a R,4S,7R,7a S)-2-{(1R,2R)-2- [4-(1,2-benzisothiazol-3-yl) pipérazin-1-ylméthyl] cyclohexylméthyl} hexahydro-4,7-méthano-2 H-isoindole-1,3-dione). Le procédé consiste en la réaction du composé-III (tel que décrit ici) avec le composé-IV (tel que décrit ici) en présence d'un mélange de solvants choisis parmi un alcool et de l'eau ; et une base. Le procédé amélioré pour la préparation du composé II fournit le produit avec une quantité totale de composé-IV n'ayant pas réagi comme impureté inférieure à 0,06 % et le produit ayant une pureté par HPLC de ≥ 99,8 %. Le procédé concerne en outre la purification du chlorhydrate de lurasidone, le produit contenant de l'acétone résiduel en quantité < 5000 ppm. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2016110798A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2016110798A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2016110798A13</originalsourceid><addsrcrecordid>eNrjZPBy9FPw9A0I8g9zdVEAUs6uwcEKbv5BCiEerkC-a4BjkGOIp7-fgr-bgk9okGOwp4u_n6uCo5-LgmdIsIKnX4hrkK-ri6djiCsPA2taYk5xKi-U5mZQdnMNcfbQTS3Ij08tLkhMTs1LLYkP9zcyMDQzNDQwt7RwNDQmThUAESUuUQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AN IMPROVED PROCESS FOR THE PREPARATION OF LURASIDONE AND ITS INTERMEDIATE</title><source>esp@cenet</source><creator>ZALTE, YOGESH ; TIWARI, SHASHI KANT ; WARPE, MANIKRAO ; WAGH, GANESH ; KRISHNMURTHY, DHILEEPKUMAR ; GHARPURE, MILIND ; REVANAPPA, GALGE</creator><creatorcontrib>ZALTE, YOGESH ; TIWARI, SHASHI KANT ; WARPE, MANIKRAO ; WAGH, GANESH ; KRISHNMURTHY, DHILEEPKUMAR ; GHARPURE, MILIND ; REVANAPPA, GALGE</creatorcontrib><description>The present invention provides an improved process for preparation of the substantially pure (3a R,7a R)-4'-(benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,1'-piperazin]-1'-ium methanesulfonate (referred to as compound-II), which is useful as a key intermediate for the synthesis of lurasidone ((3a R,4S,7R,7a S)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3- yl)piperazin-1ylmethyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione). The process comprises reaction of the compound-III (as described herein) with the compound-IV (as described herein) in the presence of a solvent mixture selected from an alcohol and water; and a base The improved process for the preparation of compound II provides the product with total amount of unreacted compound-IV as impurity in less than 0.06 % and the product with HPLC purity as ≥ 99.8%. The process further refers purification of Lurasidone hydrochloride, wherein the product contains the residual acetone < 5000 ppm.
La présente invention concerne un procédé amélioré de préparation du (3a R,7a R) -4 '- (benzo [d] isothiazol -3-yl) octahydrospiro [isoindole -2,1 '-pipérazin]-1 '-ium méthanesulfonate sensiblement pur (désigné composé -II), qui est utile comme intermédiaire clé pour la synthèse du lurasidone ((3a R,4S,7R,7a S)-2-{(1R,2R)-2- [4-(1,2-benzisothiazol-3-yl) pipérazin-1-ylméthyl] cyclohexylméthyl} hexahydro-4,7-méthano-2 H-isoindole-1,3-dione). Le procédé consiste en la réaction du composé-III (tel que décrit ici) avec le composé-IV (tel que décrit ici) en présence d'un mélange de solvants choisis parmi un alcool et de l'eau ; et une base. Le procédé amélioré pour la préparation du composé II fournit le produit avec une quantité totale de composé-IV n'ayant pas réagi comme impureté inférieure à 0,06 % et le produit ayant une pureté par HPLC de ≥ 99,8 %. Le procédé concerne en outre la purification du chlorhydrate de lurasidone, le produit contenant de l'acétone résiduel en quantité < 5000 ppm.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160714&DB=EPODOC&CC=WO&NR=2016110798A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160714&DB=EPODOC&CC=WO&NR=2016110798A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZALTE, YOGESH</creatorcontrib><creatorcontrib>TIWARI, SHASHI KANT</creatorcontrib><creatorcontrib>WARPE, MANIKRAO</creatorcontrib><creatorcontrib>WAGH, GANESH</creatorcontrib><creatorcontrib>KRISHNMURTHY, DHILEEPKUMAR</creatorcontrib><creatorcontrib>GHARPURE, MILIND</creatorcontrib><creatorcontrib>REVANAPPA, GALGE</creatorcontrib><title>AN IMPROVED PROCESS FOR THE PREPARATION OF LURASIDONE AND ITS INTERMEDIATE</title><description>The present invention provides an improved process for preparation of the substantially pure (3a R,7a R)-4'-(benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,1'-piperazin]-1'-ium methanesulfonate (referred to as compound-II), which is useful as a key intermediate for the synthesis of lurasidone ((3a R,4S,7R,7a S)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3- yl)piperazin-1ylmethyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione). The process comprises reaction of the compound-III (as described herein) with the compound-IV (as described herein) in the presence of a solvent mixture selected from an alcohol and water; and a base The improved process for the preparation of compound II provides the product with total amount of unreacted compound-IV as impurity in less than 0.06 % and the product with HPLC purity as ≥ 99.8%. The process further refers purification of Lurasidone hydrochloride, wherein the product contains the residual acetone < 5000 ppm.
La présente invention concerne un procédé amélioré de préparation du (3a R,7a R) -4 '- (benzo [d] isothiazol -3-yl) octahydrospiro [isoindole -2,1 '-pipérazin]-1 '-ium méthanesulfonate sensiblement pur (désigné composé -II), qui est utile comme intermédiaire clé pour la synthèse du lurasidone ((3a R,4S,7R,7a S)-2-{(1R,2R)-2- [4-(1,2-benzisothiazol-3-yl) pipérazin-1-ylméthyl] cyclohexylméthyl} hexahydro-4,7-méthano-2 H-isoindole-1,3-dione). Le procédé consiste en la réaction du composé-III (tel que décrit ici) avec le composé-IV (tel que décrit ici) en présence d'un mélange de solvants choisis parmi un alcool et de l'eau ; et une base. Le procédé amélioré pour la préparation du composé II fournit le produit avec une quantité totale de composé-IV n'ayant pas réagi comme impureté inférieure à 0,06 % et le produit ayant une pureté par HPLC de ≥ 99,8 %. Le procédé concerne en outre la purification du chlorhydrate de lurasidone, le produit contenant de l'acétone résiduel en quantité < 5000 ppm.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPBy9FPw9A0I8g9zdVEAUs6uwcEKbv5BCiEerkC-a4BjkGOIp7-fgr-bgk9okGOwp4u_n6uCo5-LgmdIsIKnX4hrkK-ri6djiCsPA2taYk5xKi-U5mZQdnMNcfbQTS3Ij08tLkhMTs1LLYkP9zcyMDQzNDQwt7RwNDQmThUAESUuUQ</recordid><startdate>20160714</startdate><enddate>20160714</enddate><creator>ZALTE, YOGESH</creator><creator>TIWARI, SHASHI KANT</creator><creator>WARPE, MANIKRAO</creator><creator>WAGH, GANESH</creator><creator>KRISHNMURTHY, DHILEEPKUMAR</creator><creator>GHARPURE, MILIND</creator><creator>REVANAPPA, GALGE</creator><scope>EVB</scope></search><sort><creationdate>20160714</creationdate><title>AN IMPROVED PROCESS FOR THE PREPARATION OF LURASIDONE AND ITS INTERMEDIATE</title><author>ZALTE, YOGESH ; TIWARI, SHASHI KANT ; WARPE, MANIKRAO ; WAGH, GANESH ; KRISHNMURTHY, DHILEEPKUMAR ; GHARPURE, MILIND ; REVANAPPA, GALGE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2016110798A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZALTE, YOGESH</creatorcontrib><creatorcontrib>TIWARI, SHASHI KANT</creatorcontrib><creatorcontrib>WARPE, MANIKRAO</creatorcontrib><creatorcontrib>WAGH, GANESH</creatorcontrib><creatorcontrib>KRISHNMURTHY, DHILEEPKUMAR</creatorcontrib><creatorcontrib>GHARPURE, MILIND</creatorcontrib><creatorcontrib>REVANAPPA, GALGE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZALTE, YOGESH</au><au>TIWARI, SHASHI KANT</au><au>WARPE, MANIKRAO</au><au>WAGH, GANESH</au><au>KRISHNMURTHY, DHILEEPKUMAR</au><au>GHARPURE, MILIND</au><au>REVANAPPA, GALGE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AN IMPROVED PROCESS FOR THE PREPARATION OF LURASIDONE AND ITS INTERMEDIATE</title><date>2016-07-14</date><risdate>2016</risdate><abstract>The present invention provides an improved process for preparation of the substantially pure (3a R,7a R)-4'-(benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,1'-piperazin]-1'-ium methanesulfonate (referred to as compound-II), which is useful as a key intermediate for the synthesis of lurasidone ((3a R,4S,7R,7a S)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3- yl)piperazin-1ylmethyl] cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione). The process comprises reaction of the compound-III (as described herein) with the compound-IV (as described herein) in the presence of a solvent mixture selected from an alcohol and water; and a base The improved process for the preparation of compound II provides the product with total amount of unreacted compound-IV as impurity in less than 0.06 % and the product with HPLC purity as ≥ 99.8%. The process further refers purification of Lurasidone hydrochloride, wherein the product contains the residual acetone < 5000 ppm.
La présente invention concerne un procédé amélioré de préparation du (3a R,7a R) -4 '- (benzo [d] isothiazol -3-yl) octahydrospiro [isoindole -2,1 '-pipérazin]-1 '-ium méthanesulfonate sensiblement pur (désigné composé -II), qui est utile comme intermédiaire clé pour la synthèse du lurasidone ((3a R,4S,7R,7a S)-2-{(1R,2R)-2- [4-(1,2-benzisothiazol-3-yl) pipérazin-1-ylméthyl] cyclohexylméthyl} hexahydro-4,7-méthano-2 H-isoindole-1,3-dione). Le procédé consiste en la réaction du composé-III (tel que décrit ici) avec le composé-IV (tel que décrit ici) en présence d'un mélange de solvants choisis parmi un alcool et de l'eau ; et une base. Le procédé amélioré pour la préparation du composé II fournit le produit avec une quantité totale de composé-IV n'ayant pas réagi comme impureté inférieure à 0,06 % et le produit ayant une pureté par HPLC de ≥ 99,8 %. Le procédé concerne en outre la purification du chlorhydrate de lurasidone, le produit contenant de l'acétone résiduel en quantité < 5000 ppm.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2016110798A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | AN IMPROVED PROCESS FOR THE PREPARATION OF LURASIDONE AND ITS INTERMEDIATE |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T02%3A36%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZALTE,%20YOGESH&rft.date=2016-07-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2016110798A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |